Disparities in Direct Oral Anticoagulant Initiation Have Declined in Recent Years
By Lori Solomon HealthDay Reporter
FRIDAY, May 10, 2024 -- Historical disparities in initiation of direct oral anticoagulants (DOACs) for atrial fibrillation have lessened for Black and Hispanic patients, according to a study published online May 6 in JAMA Network Open.
Kamika R. Reynolds, Ph.D., from the Institute for Health, Health Care Policy and Aging Research at Rutgers University in New Brunswick, New Jersey, and colleagues investigated disparities in the initiation of DOACs compared to warfarin by race, ethnicity, and social vulnerability. The analysis included a 50 percent sample of Medicare fee-for-service data (2010 through 2019) to identify 950,698 anticoagulation initiations among U.S. adults (aged 65 years and older) with atrial fibrillation.
The researchers found that during the 10-year study period, DOAC use increased for all demographic groups. Compared with White patients, Black and Hispanic patients were less likely to initiate DOAC use. During the study period, disparities in DOAC initiation among Black patients attenuated and became nonsignificant by 2019 compared with the early years.
"This study highlights the evolution of management of atrial fibrillation, underscoring historical imbalances that have shown signs of abatement," the authors write. "Identifying the factors behind these early disparities is crucial for ensuring equitable access to novel therapies as they emerge for Black and Hispanic populations."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Pulsed Field Ablation Demonstrates Favorable Safety Profile for A-Fib
THURSDAY, July 11, 2024 -- For patients with atrial fibrillation (AF), pulsed field ablation (PFA) demonstrates a favorable safety profile, according to a study published online...
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib
MONDAY, July 8, 2024 -- For patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates...
Gastroesophageal Reflux Disease Increases Risk for Atrial Fibrillation
TUESDAY, July 2, 2024 -- Gastroesophageal reflux disease (GERD) is associated with an increased incidence of atrial fibrillation, according to a study published online June 2...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.